Green Technology Metals(GT1:AU) has announced EDC Extends LOI for Seymour Lithium Project of up to C$100m
Download the PDF here.
Green Technology Metals(GT1:AU) has announced EDC Extends LOI for Seymour Lithium Project of up to C$100m
Download the PDF here.
Red Metal Resources Ltd. (CSE: RMES,OTC:RMESF) (OTC Pink: RMESF) (FSE: I660) (‘Red Metal’ or the ‘Company’) is pleased to announce a financing.
Private placement offering
Red Metal announces a non-brokered private placement offering for gross proceeds of up to C$750,000 for an aggregate of up to 12,500,000 units (the ‘Offering‘).
The Company intends to raise up to $750,000 by issuing an aggregate of up to 12,500,000 units at a price of $0.06 per unit (the ‘Units’). Each Unit shall be comprised of one common share in the capital of the Company (each a ‘Share‘) and one Common Share purchase warrant (each a ‘Warrant‘). Each Warrant entitles the subscriber to purchase one additional Share of the Company ( a ‘Warrant Share’) for a period of three years at a price of CDN$0.09 per Warrant Share in the first year following the close of the financing, CDN$0.12 per Warrant Share in the second year following the close of the financing, CDN$0.15 per Warrant Share in the third year following the close of the financing.
The Company intends to use the proceeds from the sale of the Units to finance general working capital requirements and exploration on Carrizal, its flagship Chilean copper property.
States CEO Caitlin Jeffs, ‘With a pro-business and mining government in Chile, and with copper reaching record prices, we believe now is the time to focus on our Chile copper project. We intend to use the funds to advance exploration on Carrizal and for general working capital.’
All securities to be issued under the Offering will be subject to a four-month-and-one-day hold period in accordance with applicable Canadian securities laws.
About Red Metal Resources Ltd.
Red Metal Resources is a mineral exploration company focused on growth through acquiring, exploring and developing clean energy and strategic minerals projects. The Company’s current portfolio include the 100% owned Ville Marie claims in Quebec, Canada as well as Company’s Chilean projects which are located in the prolific Candelaria iron oxide copper-gold (IOCG) belt of Chile’s coastal Cordillera. Red Metal is quoted on the Canadian Securities Exchange under the symbol RMES, on OTC Link alternative trading system on the OTC Pink marketplace under the symbol RMESF and on the Frankfurt Stock Exchange under the symbol I660.
For more information, visit www.redmetalresources.com
Contact:
Red Metal Resources Ltd.
Caitlin Jeffs, President & CEO
1-866-907-5403
invest@redmetalresources.com
www.redmetalresources.com
Forward-Looking Statements – All statements in this press release, other than statements of historical fact, are ‘forward-looking information’ within the meaning of applicable securities laws including, without limitation statements related to the Offering and expected use of proceeds. Red Metal provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited to the ability to raise adequate financing, receipt of required approvals, as well as those risks and uncertainties identified and reported in Red Metal’s public filings under its SEDAR+ profile at www.sedarplus.ca. Although Red Metal has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Red Metal disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.
Neither the Canadian Securities Exchange nor the Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
THIS NEWS RELEASE IS NOT FOR DISSEMINATION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/279761
News Provided by Newsfile via QuoteMedia
The copper price climbed to a fresh record on Tuesday (January 6), with persistent supply disruptions and trade uncertainty pushing the metal to a nearly 30 percent rally since October.
Benchmark three month copper on the London Metal Exchange (LME) rose as much as 3.1 percent in early trading to an all‑time high of US$13,387.50 per metric ton before settling slightly lower, but still above US$13,200.
The jump marks another milestone in a rally that first saw copper breach US$12,000 late in December last year.
Copper is widely used across the industrial economy, from construction and power infrastructure to electric vehicles and data centers that support artificial intelligence growth. Analysts attribute the gains to a combination of production setbacks at major mines and heightened concerns that prospective US trade tariffs could further disrupt flows.
Large copper-mining operations such as Freeport-McMoRan’s (NYSE:FCX) Grasberg complex in Indonesia have faced challenges since last year, while a strike at Capstone Copper’s (TSX:CS,ASX:CSC,OTC Pink:CSCCF) Mantoverde mine in Chile has reduced output prospects in one of the world’s top copper‑producing nations.
The threat of new tariffs under the Trump administration has also shaped expectations. Traders have moved to ship refined copper into the US ahead of any potential levies, tightening supply elsewhere. Furthermore, data show copper stocks in Comex warehouses have jumped to more than 450,000 metric tons, well above last year’s levels.
Market watchers expect many of the forces that drove copper through 2025 to persist.
Supply constraints are expected to remain acute this year as aging mines and capacity shortfalls weigh on availability. New projects such as Arizona Sonoran Copper Company’s (TSX:ASCU,OTCQX:ASCUF) Cactus project and the long‑anticipated Resolution mine in the US are still years from significant output.
Copper demand is projected to grow as the global energy transition accelerates.
“A huge amount of this tightness has to do with US tariff concerns,” she said.
China, the world’s largest copper consumer, is also shaping the outlook. Despite weakness in its property sector, the country posted economic growth and is expected to prioritize copper‑intensive sectors under its new five year plan.
Longer‑term projections from industry groups suggest structural demand growth will outpace supply additions.
A UN report estimates that copper demand could rise 40 percent by 2040, requiring substantial investment and new mines just to keep pace. Likewise, Wood Mackenzie forecasts that copper demand will increase 24 percent by 2035, while the International Copper Study Group predicts a refined copper deficit of 150,000 metric tons in 2026 alone.
Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.
E-Power Resources offers investors high-grade exposure to the rapidly expanding flake graphite sector through one of Québec’s most promising districts. With a strategic land position, near-surface discoveries, and a leadership team experienced in exploration and capital markets, E-Power is positioned to help supply North America’s critical battery materials chain.
E-Power Resources (CSE:EPR) is a Montréal-based company focused on advancing its flagship Tetepisca graphite property in Québec’s North Shore region. The company’s mission is to delineate and develop a high-grade, near-surface flake-graphite resource capable of supplying future North American battery-anode demand.
Since entering the Tetepisca district in 2019, E-Power has systematically advanced its project from regional geophysics to mapping, sampling, drilling and metallurgical testing. This disciplined exploration pipeline has confirmed the presence of district-scale, high-purity graphite mineralization within the same geological sequence that hosts neighboring deposits such as Focus Graphite’s Lac Tetepisca and Nouveau Monde Graphite’s Uatnan, which together hold more than 120 million tons (Mt) measured + indicated at approximately 14 percent Cg.
Graphite demand is accelerating globally as electric-vehicle production and energy-storage capacity expand. Québec’s hydroelectric grid, pro-mining policy environment, and rapidly developing anode-manufacturing infrastructure make it a world-class jurisdiction for low-carbon graphite development. Within this setting, E-Power’s land position, grade profile and technical results uniquely position the company to become a core participant in Canada’s graphite-to-battery supply chain.
The Tetepisca graphite property is approximately 220 km north of Baie-Comeau, covering 234 contiguous claims (~12,840 ha) in the heart of the Tetepisca Graphite District (TGD). The property is 100-percent-owned by E-Power and hosts the same graphitic metasedimentary units that define the district’s producing and feasibility-stage assets.
The TGD is an emerging flake-graphite camp that now hosts more than 120 Mt of measured and indicated resources averaging ~14 percent Cg across nearby projects such as Nouveau Monde Graphite’s Uatnan and Focus Graphite’s Lac Tetepisca deposits.
E-Power controls the largest contiguous land position in the district, strategically covering the same graphitic metasedimentary horizons that host these deposits. The district’s proximity to the planned 200,000 tpy graphite-anode facility in Baie-Comeau creates a unique alignment of resource, infrastructure and processing capability, positioning E-Power as a potential key upstream feed source for Québec’s integrated graphite-to-anode supply chain.
E-Power’s work since 2021 has validated the property’s high-grade, near-surface potential.
E-Power’s 2025–2026 work program will focus on advancing the Tetepisca property toward an initial resource estimate. Key activities include expanded fieldwork and metallurgical testing at the Graphi-Centre, Captain Cosmos and Syndicate showings; follow-up ground and drone-borne geophysical surveys to refine drill targets; and a focused drilling campaign designed to define near-surface, high-grade graphite zones. In parallel, the company is initiating early environmental baseline and access studies to support future development and potential partnerships within Québec’s growing graphite-to-anode supply chain.
Jean-Michel Gauthier contributes significant expertise in capital markets, corporate development and strategic positioning within the resource sector. His focus will be on ensuring the optimal deployment of capital and maximizing the inherent value of the Tetepisca Project as it advances through key de-risking stages.
Mark Billings is a highly respected finance professional in the Canadian resource sector, bringing extensive investment banking and corporate finance experience. His prior roles, including VP corporate finance at Desjardins Securities, provide a crucial foundation for guiding E-Power’s capital formation and strategic financing plans necessary for the Tetepisca Project’s development phases.
Jamie Lavigne is a professional economic geologist with over 30 years of experience in exploration and mine development. He has worked with major Canadian and Australian mining companies and several junior explorers and operates his own consulting firm. Lavigne holds a B.Sc. from Memorial University and an MSc. from the University of Ottawa. He is a member of L’Ordre des Géologues du Québec and the Northwest Territories and Nunavut Association of Professional Engineers and Geoscientists.
Paul Haber brings over 20 years of experience in corporate finance and capital markets. He has served as CFO, board member, and audit chair for numerous public and private companies, including XTM (CSE:PAID), South American Silver (TSX:SAC), and Migao Corporation (TSX:MGO). A CPA and CA, Haber began his career at Coopers & Lybrand and holds an Honours B.A. in Management from the University of Toronto. He also holds a Chartered Director designation from the DeGroote School of Business and the Conference Board of Canada.
Discoveries made by companies in the genetics sector help support every other life science industry in a variety of ways.
One of the genetic sector’s major contributions is the discovery of new genetic drivers of diseases. Genetic testing has grown substantially over the last few years, thanks to advances in technology; growth has also been spurred by an increase in chronic diseases and the continuing development of test kits for therapeutic areas with unmet medical needs.
Gene therapy is also a huge driver of growth in the overarching genetics market. This important segment of the life science market is focused on how genes can help treat or prevent serious conditions in patients. This includes the potential for healthcare professionals to implement gene therapy at the cellular level instead of using medication or surgery, replacing ‘faulty’ genes with new ones to potentially cure diseases.
Pharma and biotech companies often dabble in genetics along with their core disciplines, meaning that some firms may also have operations in other areas.
The top NASDAQ genetics stocks listed below have products related to gene therapy, genetic testing, genetically defined cancers and rare genetic diseases.
Data for this list of genetics stocks on the NASDAQ was collected on December 31, 2025, using TradingView’s stock screener, and stocks with market caps above US$50 million were considered.
Year-over-year gain: 143.8 percent
Market cap: US$10.87 billion
Share price: US$72.14
Avidity Bioscience is a biopharma firm developing a new form of RNA therapy called antibody oligonucleotide conjugates (AOC) that target the genes causing rare muscle diseases.
Through its proprietary AOC platform, Avidity developed programs for three rare muscle diseases: AOC 1001 for myotonic dystrophy type 1, AOC 1044 for Duchenne muscular dystrophy and AOC 1020 for facioscapulohumeral muscular dystrophy. The company is also working to expand its pipeline into cardiology and immunology.
In October 2025, Avidity entered into a definitive agreement to be acquired by Novartis (NYSE:NVS), which will include the company’s late-stage neuromuscular programs (AOC 1001, 1020, 1044) and the AOC platform, for US$12 billion.
Avidity’s early-stage precision cardiology programs will spin off into a new public company prior to closing in H1 2026. The spin-off will also have rights to use and develop the AOC platform for cardiology applications.
Year-over-year gain: 36.52 percent
Market cap: US$3.13 billion
Share price: US$17.12
Wave Life Sciences is another clinical-stage firm focused on unlocking insights from human genetics to deliver RNA-based medicines. The company’s PRISM platform is targeting both rare and prevalent disorders. Its pipeline includes clinical programs for Duchenne muscular dystrophy, alpha-1 antitrypsin deficiency and Huntington’s disease, as well as a preclinical program for WVE-007 in obesity.
Wave Life Sciences advanced its PRISM RNA platform across multiple programs in 2025. It is also performing a Phase 1 trial testing its WVE-007 obesity candidate, which is an investigational INHBE GalNAc-siRNA using Wave’s proprietary SpiNA design.
In December, the company reported positive interim data from the WVE-007 trial, which showed that a single dose resulted in sustained Activin E reduction, supporting infrequent dosing. Target engagement updates and body composition readouts are planned for Q1 2026.
Year-over-year gain: 33.15 percent
Market cap: US$1.47 billion
Share price: US$23.86
UniQure is a gene therapy company focused on patients with severe medical needs. In November 2022, the US Food and Drug Administration (FDA) approved the company’s gene therapy Hemgenix (etranacogene dezaparvovec), which is the world’s first gene therapy for hemophilia B.
Today, uniQure’s proprietary gene therapy pipeline includes treatments for patients with Huntington’s disease, refractory temporal lobe epilepsy, ALS and Fabry disease.
Its gene therapy pipeline advanced in 2025, with positive Phase I/II topline data for Huntington’s disease candidate AMT-130 showing 75 percent slowing of disease progression at three years via cUHDRS, alongside 60 percent functional capacity preservation.
While data from the Phase I/II study led the FDA to grant AMT-130 breakthrough therapy designation in April, in December the agency told UniQure it believes the data may not be adequate to support a pre-biologics license application under the accelerated approval pathway. The company is pursuing a follow-up meeting.
Year-over-year gain: 186.96 percent
Market cap: US$1.81 billion
Share price: US$31.74
Stoke Therapeutics is another biotech company with a focus on developing RNA medicine. With its proprietary research platform TANGO, which stands for targeted augmentation of nuclear gene output, the company is developing antisense oligonucleotides to selectively restore protein levels.
Stoke’s first product candidate, zorevunersen (STK-001), is in clinical testing for the treatment of Dravet syndrome, a severe form of genetic epilepsy. The company is also developing STK-002 for the treatment of autosomal dominant optic atrophy, an inherited optic nerve disorder.
Both candidates advanced in 2025, with STK-001 enrolling patients in Phase 3 after positive long-term data showed seizure reductions and cognitive gains. Likewise, STK-002’s clinical development program is being informed by results, presented in October, of a Phase 1 two year natural history study on the disease progression of autosomal dominant optic atrophy.
Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.
Alain Corbani, head of mining at Montbleu Finance and manager of the Global Gold and Precious Fund, sees the gold price reaching US$5,000 per ounce in the near term.
He sees real interest rates and the US dollar as the key factors to watch, but noted that other elements are also adding tailwinds.
Securities Disclosure: I, Charlotte McLeod, hold no direct investment interest in any company mentioned in this article.
Sen. Bernie Sanders, I-Vt., railed against President Donald Trump’s weekend strikes in Venezuela, but his criticism comes after a history of taking a softer approach to socialist dictators like former Venezuelan President Nicolás Maduro.
Sanders, like several of his colleagues in the Senate Democratic caucus, argued that Trump’s decision to strike Venezuela’s capital Caracas without congressional approval broke the law and was another instance of the administration leapfrogging Congress’ war powers.
‘Donald Trump has, once again, shown his contempt for the Constitution and the rule of law,’ Sanders said in a statement. ‘The President of the United States does NOT have the right to unilaterally take this country to war, even against a corrupt and brutal dictator like Maduro.’
But the lawmaker’s decision to call Maduro a dictator is a shift. In previous years, Sanders has declined to place that label on him.
When Sanders was on the presidential campaign trail in 2019, he opted not to call Maduro a dictator, instead saying he would support an effort to ensure free and fair elections in the country.
‘I think it’s fair to say that the last election was undemocratic, but there are still Democratic operations taking place in that country,’ Sanders said during a town hall at the time. ‘The point is, what I’m calling for right now is an internationally supervised fair election.’
Maduro, who was first elected in 2013, is accused of human rights abuses and working with cartels and narco gangs in South America and Mexico to distribute illicit drugs into the U.S.
However, Sanders has often accused Trump of engaging in authoritarianism.
‘Under this administration, authoritarianism has taken root in our country,’ Sanders said on X in 2020. ‘As long as I am here, I will work with progressives, with moderates, and, yes, with conservatives to preserve this nation from a threat that so many of our heroes fought and died to defeat.’
The lawmaker has also been supportive of policies under former Cuban dictator Fidel Castro. During his last presidential run, Sanders came under fire after a speech he made in the 1980s when he lauded the socialist policies installed by Castro and his regime.
Sanders was pressed on the speech during another town hall event on the campaign trail, where he noted that he had been consistently critical of authoritarian regimes across the globe.
Still, he contended that ‘there were a lot of folks in Cuba at that point who were illiterate. He formed the literacy brigade.’
‘You know what, I think teaching people to read and write is a good thing,’ Sanders said.
Fox News Digital did not immediately hear back from Sanders’ office for comment.
Sen. Ruben Gallego, D-Ariz., introduced legislation aimed at blocking President Donald Trump from invading Greenland on Tuesday.
Gallego announced the legislative push on X, saying Congress must stop Trump ‘before he invades another country on a whim.’ The bill is one of several Democrat-backed efforts seeking to stop Trump from taking military action against other countries following the capture of now former Venezuelan President Nicolás Maduro.
‘Families are getting crushed by rising grocery and housing costs, inflation is up, and Trump’s name is all over the Epstein files. Instead of doing anything to fix those problems, Trump is trying to distract people by threatening to start wars and invade countries – first in Venezuela, and now against our NATO ally Denmark,’ Gallego said in a statement.
‘What’s happening in Venezuela shows us that we can’t just ignore Trump’s reckless threats. His dangerous behavior puts American lives and our global credibility at risk. I’m introducing this amendment to make it clear that Congress will not bankroll illegal, unnecessary military action, and to force Republicans to choose whether they’re going to finally stand up or keep enabling Trump’s chaos,’ he added.
President Donald Trump told reporters on Air Force One over the weekend that the U.S. needs Greenland, a Danish territory, for ‘national security.’
White House deputy chief of staff for policy Stephen Miller doubled down on Trump’s remarks on Monday, telling CNN that Greenland ‘should be part of the United States.’
CNN anchor Jake Tapper pressed Miller about whether the Trump administration could rule out military action to take the Arctic island.
‘Greenland has a population of 30,000 people,’ Miller said. ‘The real question is by what right does Denmark assert control over Greenland. What is the basis of their territorial claim? What is their basis of having Greenland as a colony of Denmark?’
‘The United States is the power of NATO. For the United States to secure the Arctic region, to protect and defend NATO and NATO interests, obviously Greenland should be part of the United States,’ he added.
Greenlandic Prime Minister Jens-Frederik Nielsen said in a Monday statement posted on Facebook that his country is ‘not an object of superpower rhetoric.’
Danish Prime Minister Mette Frederiksen argued that a U.S. takeover of Greenland would effectively destroy NATO.
‘But I also want to make it clear that if the U.S. chooses to attack another NATO country militarily, then everything stops. Including our NATO and thus the security that has been provided since the end of the Second World War,’ she said.
Fox News’ Ashley Carnahan contributed to this report.
Minnesota Gov. Tim Walz’s announcement that he is dropping his re-election bid amid a massive fraud scandal in the state is raising questions about the vetting process he received to be Kamala Harris’ running mate.
Following Walz’s Monday announcement that he will not run for re-election as the state faces a fraud scandal that prosecutors say could total as much as $9 billion, many on social media from both sides of the aisle wondered aloud why he was elevated to the presidential ticket despite the fraud concerns which date back to at least 2019 when he was elected governor.
‘What did Kamala Harris’ veep vetting team know about Tim Walz, and when did they know it?’ Conservative commentator and columnist Josh Hammer posted on X.
‘This will dog VP Harris and she will need to answer questions about Tim Walz and her answers need to be CLEAR.’ former Jill Biden Press Secretary Michael LaRosa posted on X. ‘If I were advising the former VP, I would put this to bed NOW and release a statement ASAP. Rip the Band-Aid off and get this behind her. Her judgment will be questioned and the trust she placed into those who vetted her VP options will also be questioned. How could they possibly have missed this?’
Harris released a statement later in the day wishing Walz the best and touting his ‘life in public service’ but did not specifically address the fraud scandal or vetting process.
‘The vetting clearly failed,’ retired Minnesota State Patrol Lt. John Nagel told Fox News Digital. Nagel is running for Congress as a Republican against Democratic Rep. Ilhan Omar.
‘By the time Governor Tim Walz was selected, Minnesota’s fraud scandals were already public, already under federal investigation, and already raising serious questions about oversight. That wasn’t hidden information — it was an open and growing issue, despite a local media environment that protects Democrats.’
Former Obama-era attorney general Eric Holder was a key figure in the vetting process for the Harris campaign, and he defended his due diligence on Walz, telling CNN that ‘nothing of substance’ was missed in regard to Walz’s record, which Nagel told Fox News Digital ‘raised more questions than it answered’ given the visibility of fraud concerns.
‘Either possibility is troubling,’ Nagel told Fox News Digital. ‘If Kamala Harris didn’t know, that points to a deeply flawed vetting process and an insane level of hubris. If she did know and proceeded anyway, that suggests accountability simply wasn’t a priority.’
Michael Ceraso, a veteran Democratic strategist, told Fox News Digital the Harris campaign was likely aware of the fraud reports, but internally compared it to Trump’s controversies and concluded it’s ‘not as bad.’
‘Maybe the standard was different because they understood who they were running against, and maybe they were blasé about it because they were looking at their opponent and saying, well, this may not be as comparable to this, and so we can excuse this because this guy over here has done X, Y, and Z,’ Ceraso explained.
Going forward, Ceraso said the Democratic Party could arguably ‘put itself in a position as being the values party’ by placing more emphasis on vetting issues on their own merits rather than comparing records to Trump.
‘The Democratic Party needs to be better because we can all be better, but I think comparing ourselves to a president that we obviously disagree with morally and saying, well, we’re not as bad as that, but still let a multi-billion dollar corruption thing happen with no accountability. That’s still pretty bad.’
Nagel told Fox News Digital that if Harris decides to run for political office in the future that this issue will likely come up.
‘Voters deserve to know how decisions at the highest levels are made — and whether political considerations outweighed transparency and accountability,’ Nagel said. ‘Unfortunately, if Kamala decides to run in 2028, legacy media outlets will likely not press her on her choice of Walz. I expect that to only be raised in Democrat circles during a presidential debate during the primaries.’
Fox News Digital reached out to Harris’ office for comment.
Walz has also faced criticism in recent days for comments he made on the campaign trail touting childcare programs in Minnesota, suggesting it should be a model for the nation, even though the Feeding Our Future scandal had been bubbling for years.
Pro-life activists and groups are taking issue with President Donald Trump’s remarks to Republican lawmakers to be ‘flexible’ on a law that bans the use of federal funds for most abortions as health care talks continue in Congress.
‘Any healthcare plan that prioritizes a ‘deal’ over saving lives — in and out of the womb — deserves to die, not children,’ Students for Life Action President Kristan Hawkins said in a statement Tuesday following Trump’s address. ‘Republicans need to fix what the Democrats profoundly broke. Former President Barack Obama destroyed the American healthcare system with Obamacare, driving up costs and pushing life-ending policies with taxpayer funds. The GOP must work not for any deal, but for the right deal.’
Trump joined Republican House lawmakers Tuesday morning at the newly renamed Trump–Kennedy Center during their annual policy retreat to discuss the party’s agenda for the coming year — a high-stakes election cycle with the midterms just over a year away. Lawmakers are working to revive Obamacare enhanced subsidies after they expired in 2025, with some Republicans new restrictions on federal funds as they relate to abortion services under Obamacare plans.
Trump said Tuesday lawmakers should be ‘flexible’ on the Hyde Amendment — a long-standing appropriations rider enacted in 1976 — that bars most federal funding for abortion, including through Medicaid, with limited exceptions.
‘You have to be a little flexible on Hyde, you know that,’ Trump said. ‘You gotta be a little flexible. You gotta work something … we’re all big fans of everything. But you have to have flexibility.’
The comment set off criticism among conservatives and pro-lifers on social media, with many remarking they can’t be ‘flexible’ when it comes to the life a child.
‘No President Trump, we will NEVER compromise on the Hyde Amendment. NO taxpayer funding of abortions. Period,’ pro-life outlet Life News posted to X.
‘For decades, opposition to taxpayer funding of abortion and support for the Hyde Amendment has been an unshakeable bedrock principle and a minimum standard in the Republican Party. To suggest Republicans should be ‘flexible’ is an abandonment of this decades-long commitment. If Republicans abandon Hyde, they are sure to lose this November,’ SBA Pro-Life America President Marjorie Dannenfelser said in a statement.
”You have to be a little flexible on Hyde’ when passing healthcare legislation, President Donald Trump just told the House Republican retreat. The Hyde Amendment prevents your taxpayer money from funding elective abortions not carried out due to rape or incest. Hard pass,’ Eastern Orthodox priest Ben Johnson posted to X.
Sen. James Lankford (R-OK) told Politico after Trump’s address that: ‘I’m not flexible on the value of every child’s life. Children are valuable, and so I’d have to get up to the context of what he meant by that.’
‘I almost fell out of my chair,’ another lawmaker told the outlet under the condition of anonymity.
Fox News Digital reached out to the White House Tuesday for additional details on Trump’s comment and response to conservatives’ concerns, but did not immediately receive a reply.
Just nearly a year ago, Trump doubled down on his support for the Hyde Amendment when he signed an executive order four days after he was sworn back into office titled, ‘ENFORCING THE HYDE AMENDMENT.’
The executive order directed federal agencies to implement restrictions on the use of federal funds for abortion, while reinforcing the long-standing Hyde Amendment and rescinding previous Biden-era orders that expanded abortion access.
‘It is the policy of the United States, consistent with the Hyde Amendment, to end the forced use of Federal taxpayer dollars to fund or promote elective abortion,’ the executive order stated.
Democrats campaigned against Trump in 2024 on claims he would wipe out abortion access and impose a national abortion ban, which the campaign brushed off as unrealistic. While some conservatives have previously taken issue with Trump for not being more vocal in his support of pro-life policies, including in 2024 when the GOP platform only mentioned abortion once, instead focusing on the preservation of life and returning power to the states when developing laws surrounding abortion.